α2A adrenoceptors regulate phosphorylation of microtubule-associated protein-2 in cultured cortical neurons

Neuroscience

Volumn 123, Issue 2, 2004, Pages 405-418

  Song, Z M ^a   Abou Zeid, O ^a   Fang, Y Y ^a,b  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptor; Cell culture; Cortex; Fetal; Mouse; Neuronal development

Indexed keywords

2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; AZEPEXOLE; BRIMONIDINE; GUANFACINE; IMILOXAN; MICROTUBULE ASSOCIATED PROTEIN 2; RAUWOLSCINE; SERINE; THREONINE; YOHIMBINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOSKELETON PROTEIN; MIP PROTEIN, BOS TAURUS; RECEPTOR, ADRENERGIC, ALPHA 2A; RECEPTOR, ADRENERGIC, ALPHA-2A;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL GROWTH; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; EMBRYO; HYPOTHESIS; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; ANIMAL; BRAIN CORTEX; CELL CULTURE; CONFOCAL MICROSCOPY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METABOLISM; NERVE CELL; PHOSPHORYLATION; PRENATAL DEVELOPMENT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; CYTOSKELETAL PROTEINS; EMBRYO; IMMUNOHISTOCHEMISTRY; MICE; MICROSCOPY, CONFOCAL; NEURONS; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0347418179     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.09.018     Document Type: Article

References (75)

1. Abdel-Majid R.M., Leong W.L., Smallman D.S., Wong S.T., Storm D.R., Fine A., Dobson M.J., Guernsey D.L., Neumann P.E. Loss of adenylyl cyclase I activity disrupts patterning of mouse somatosensory cortex. Nat Genet. 19:1998;289-291.
2. Alexa A., Schmidt G., Tompa P., Ogueta S., Vazquez J., Kulcsar P., Kovacs J., Dombradi V., Friedrich P. The phosphorylation state of threonine-220, a uniquely phosphatase-sensitive protein kinase A site in microtubule- associated protein MAP2c, regulates microtubule binding and stability. Biochemistry. 41:2002;12427-12435.
3. (+)- ATPase activity in renal tubule cells. Proc Natl Acad Sci USA. 89:1992;7394-7397.
4. Audesirk G., Cabell L., Kern M. Modulation of neurite branching by protein phosphorylation in cultured rat hippocampal neurons. Brain Res Dev Brain Res. 102:1997;247-260.
5. Baptiste D.C., Hartwick A.T., Jollimore C.A., Baldridge W.H., Chauhan B.C., Tremblay F., Kelly M.E. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina. Invest Ophthalmol Vis Sci. 43:2002;2666-2676.
6. Bean B.P. Multiple types of calcium channels in heart muscle and neurons modulation by drugs and neurotransmitters . Ann NY Acad Sci. 560:1989;334-345.
7. Beeley L.J., Berge J.M., Chapman H., Hieble P., Kelly J., Naselsky D.P., Rockell C.M., Young P.W. Synthesis of a selective α2A adrenoceptor antagonist, BRL 48962, and its characterization at cloned human α-adrenoceptors. Bioorg Med Chem. 3:1995;1693-1698.
8. Ben-Jonathan N., Maxson R.E. Elevation of dopamine in fetal plasma and the amniotic fluid during gestation. Endocrinology. 102:1978;649-652.
9. Berger-Sweeney J., Hohmann C.F. Behavioral consequences of abnormal cortical development: insights into developmental disabilities. Behav Brain Res. 86:1997;121-142.
10. Blue M.E., Parnavelas J.G. The effect of neonatal 6-hydroxydopamine treatment on synaptogenesis in the visual cortex of the rat. J Comp Neurol. 205:1982;199-205.
11. Bohmann C., Schollmeyer P., Rump L.C. α2-autoreceptor subclassification in rat isolated kidney by use of short trains of electrical stimulation. Br J Pharmacol. 108:1993;262-268.
12. Bylund D.B. Subtypes of α2-adrenoceptors pharmacological and molecular biological evidence converge . Trends Pharmacol Sci. 9:1988;346-361.
13. Bylund D.B., Ray-Prenger C., Murphy T.J. α2A and α2B adrenergic receptor subtypes antagonist binding in tissues and cell lines containing only one subtype . J Pharmacol Exp Ther. 245:1988;600-607.
14. Caviness V.S. Jr, Korde M.G. Monoaminergic afferents to the neocortex a developmental histofluorescence study in normal and Reeler mouse embryos . Brain Res. 209:1981;1-9.
15. Chabre O., Conklin B.R., Brandon S., Bourne H.R., Limbird L.E. Coupling of the α2A-adrenergic receptor to multiple G-proteins a simple approach for estimating receptor-G-protein coupling efficiency in a transient expression system . J Biol Chem. 269:1994;5730-5734.
16. Chao H.M., Osborne N.N. Topically applied clonidine protects the rat retina from ischaemia/reperfusion by stimulating α2-adrenoceptors and not by an action on imidazoline receptors. Brain Res. 904:2001;126-136.
17. Chesselet MF (1998) Localization of mRNAs encoding receptors with in situ hybridization histochemistry. In: Receptor localization: laboratory methods and procedures (Ariano MA, ed), pp 140-159. New York: John Wiley & Sons.
18. Civantos Calzada B., Alexandre de Artinano A. α-adrenoceptor subtypes. Pharmacol Res. 44:2001;195-208.
19. Cleary L., Vandeputte C., Docherty J.R. Investigation of neurotransmission in vas deferens from α2A/D-adrenoceptor knockout mice. Br J Pharmacol. 136:2002;857-864.
20. De Luca L.A. Jr, Sugawara A.M., Pereira D.T., David R.B., Menani J.V. Interaction between brain L-type calcium channels and α2-adrenoceptors in the inhibition of sodium appetite. Brain Res. 931:2002;1-4.
21. Dossin O., Mouledous L., Baudry X., Tafani J.A., Mazarguil H., Zajac J.M. Characterization of a new radioiodinated probe for the α 2C adrenoceptor in the mouse brain. Neurochem Int. 36:2000;7-18.
22. Elias M., Deacon T., Caviness V.S. The development of neocortical noradrenergic innervation in the mouse a quantitative radioenzymatic analysis . Brain Res. 255:1982;652-656.
23. Fuder H., Selbach M. Characterization of sensory neurotransmission and its inhibition via α2B-adrenoceptors and via non-α2-receptors in rabbit iris. Naunyn Schmiedebergs Arch Pharmacol. 347:1993;394-401.
24. Gong C.X., Wegiel J., Lidsky T., Zuck L., Avila J., Wisniewski H.M., Grundke-Iqbal I., Iqbal K. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res. 853:2000;299-309.
25. Goto S., Yamamoto H., Fukunaga K., Iwasa T., Matsukado Y., Miyamoto E. Dephosphorylation of microtubule-associated protein 2, τ factor, and tubulin by calcineurin. J Neurochem. 45:1985;276-283.
26. Hayashi K., Kawai-Hirai R., Ishikawa K., Takata K. Reversal of neuronal polarity characterized by conversion of dendrites into axons in neonatal rat cortical neurons in vitro. Neuroscience. 110:2002;7-17.
27. Hely T.A., Graham B., Ooyen A.V. A computational model of dendrite elongation and branching based on MAP2 phosphorylation. J Theor Biol. 210:2001;375-384.
28. Hieble J.P., Bondinell W.E., Ruffolo R.R. Jr. α- And β-adrenoceptors from the gene to the clinic: 1 . Molecular biology and adrenoceptor subclassification. J Med Chem. 38:1995;3415-3444.
29. Hiraga A., Hata K., Suzuki Y., Tsuiki S. Identification of a rat liver protein-tyrosine phosphatase similar to human placental PTPase-1B using quantitatively phosphorylated protein substrates. J Biochem (Tokyo). 113:1993;180-188.
30. Hopwood S.E., Stamford J.A. Noradrenergic modulation of serotonin release in rat dorsal and median raphe nuclei via α(1) and α(2A) adrenoceptors. Neuropharmacology. 41:2001;433-442.
31. 2+ entry blocker, on alpha-adrenoceptor-mediated pressor responses in pithed rats. Eur J Pharmacol. 238:1993;283-289.
32. Johnson G.V., Jope R.S. The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res. 33:1992;505-512.
33. Jolkkonen J., Puurunen K., Koistinaho J., Kauppinen R., Haapalinna A., Nieminen L., Sivenius J. Neuroprotection by the α2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol. 372:1999;31-36.
34. Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Annu Rev Neurosci. 15:1992;87-114.
35. Koch W.J., Hawes B.E., Inglese J., Luttrell L.M., Lefkowitz R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates Gβγ-mediated signaling. J Biol Chem. 269:1994;6193-6197.
36. 2A-adrenergic receptor stimulation potentiates calcium release in platelets by modulating cAMP levels. J Biol Chem. 275:2000;1763-1772.
37. Koszka C., Brent V.A., Rostas J.A. Developmental changes in phosphorylation of MAP-2 and synapsin I in cytosol and taxol polymerised microtubules from chicken brain. Neurochem Res. 16:1991;637-644.
38. Lafuente M.P., Villegas-Perez M.P., Sobrado-Calvo P., Garcia-Aviles A., Miralles de Imperial J., Vidal-Sanz M. Neuroprotective effects of α2-selective adrenergic agonists against ischemia-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci. 42:2001;2074-2084.
39. Laudenbach V., Mantz J., Lagercrantz H., Desmonts J.M., Evrard P., Gressens P. Effects of α2-adrenoceptor agonists on perinatal excitotoxic brain injury comparison of clonidine and dexmedetomidine . Anesthesiology. 96:2002;134-141.
40. Lauder J.M. Neurotransmitters as growth regulatory signals role of receptors and second messengers . Trends Neurosci. 16:1993;233-240.
41. Lidow M.S., Rakic P. Neurotransmitter receptors in the proliferative zones of the developing primate occipital lobe. J Comp Neurol. 360:1995;393-402.
42. Lidow M.S., Wang F. Neurotransmitter receptors in the developing cerebral cortex. Crit Rev Neurobiol. 9:1995;395-418.
43. Lipton S.A., Kater S.B. Neurotransmitter regulation of neuronal outgrowth, plasticity and survival. Trends Neurosci. 12:1989;265-270.
44. Lohof A.M., Quillan M., Dan Y., Poo M.M. Asymmetric modulation of cytosolic cAMP activity induces growth cone turning. J Neurosci. 12:1992;1253-1261.
45. López E., Arce C., Vicente S., Oset-Gasque M.J., González M.P. Nicotinic receptors mediate the release of amino acid neurotransmitters in cultured cortical neurons. Cereb Cortex. 11:2001;158-163.
46. Maccioni R.B., Cambiazo V. Role of microtubule-associated proteins in the control of microtubule assembly. Physiol Rev. 75:1995;835-864.
47. Masudi N.A., Gilmore D.P. Biogenic amine levels in the mid-term human fetus. Brain Res. 283:1983;9-12.
48. Michel A.D., Loury D.N., Whiting R.L. Assessment of imiloxan as a selective α2B-adrenoceptor antagonist. Br J Pharmacol. 99:1990;560-564.
49. Mize R.R., Graham S.K., Cork R.J. Expression of the L-type calcium channel in the developing mouse visual system by use of immunocytochemistry. Brain Res Dev Brain Res. 136:2002;185-195.
50. Nicholas A.P., Pieribone V., Hokfelt T. Distributions of mRNAs for α2 adrenergic receptor subtypes in rat brain an in situ hybridization study . J Comp Neurol. 328:1993;575-594.
51. Noblett K.L., Ariano M.A. Detection of receptor mRNA using fluorescent in situ transcription. Ariano M.A. Receptor localization laboratory methods and procedures . 1998;182-196 John Wiley & Sons.
52. Reinoso B.S., Undie A.S., Levitt P. Dopamine receptors mediate differential morphological effects on cerebral cortical neurons in vitro. J Neurosci Res. 43:1996;439-453.
53. Rowe S.J., Messenger N.J., Warner A.E. The role of noradrenaline in the differentiation of amphibian embryonic neurons. Development. 119:1993;1343-1357.
54. Sanchez C., Tompa P., Szucs K., Friedrich P., Avila J. Phosphorylation and dephosphorylation in the proline-rich C-terminal domain of microtubule-associated protein 2. Eur J Biochem. 241:1996;765-771.
55. Sanchez C., Diaz-Nido J., Avila J. Phosphorylation of microtubule-associated protein 2 (MAP2) and its relevance for the regulation of the neuronal cytoskeleton function. Prog Neurobiol. 61:2000;133-168.
56. Scheibner J., Trendelenburg A.U., Hein L., Starke K. Stimulation frequency-noradrenaline release relationships examined in α2A-, α2B- and α2C-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol. 364:2001;321-328.
57. Schlumpf M., Shoemaker W.J., Bloom F.E. Innervation of embryonic rat cerebral cortex by catecholamine-containing fibers. J Comp Neurol. 192:1980;361-376.
58. Song H.J., Poo M.M. Signal transduction underlying growth cone guidance by diffusible factors. Curr Opin Neurobiol. 9:1999;355-363.
59. Song Z.M., Undie A.S., Koh P.O., Fang Y.Y., Zhang L., Dracheva S., Sealfon S.C., Lidow M.S. D1 dopamine receptor regulation of microtubule- associated protein-2 phosphorylation in developing cerebral cortical neurons. J Neurosci. 22:2002;6092-6105.
60. Soto-Moyano R., Hernandez A., Perez H., Ruiz S., Carreno P., Alarcon S., Belmar J. Clonidine treatment during gestation prevents functional deficits induced by prenatal malnutrition in the rat visual cortex. Int J Neurosci. 76:1994;237-248.
61. Stephanie Parsley, Lucien Gazi, Ionel Bobirnac, Erika Loetscher and Philippe Schoeffter (1999) Functional α2C-adrenoceptors in human neuroblastoma SH-SY5Y cells. Eur J Pharmacol 372:109-115.
62. Tucker R.P. The roles of microtubule-associated proteins in brain morphogenesis. Brain Res Rev. 15:1990;101-120.
63. Uchida-Oka N., Sugimoto M. Norepinephrine induces apoptosis in skin melanophores by attenuating cAMP-PKA signals via α2-adrenoceptors in the medaka, Oryzias latipes. Pigment Cell Res. 14:2001;356-361.
64. Vaccarino F.M., Schwartz M.L., Hartigan D., Leckman J.F. Basic fibroblast growth factor increases the number of excitatory neurons containing glutamate in the cerebral cortex. Cereb Cortex. 1:1995;64-78.
65. Vallee R. Structure and phosphorylation of microtubule-associated protein 2 (MAP 2). Proc Natl Acad Sci USA. 77:1980;3206-3210.
66. Vidal-Sanz M., Lafuente M.P., Mayor S., de Imperial J.M., Villegas-Perez M.P. Retinal ganglion cell death induced by retinal ischemia neuroprotective effects of two α2 agonists . Surv Ophthalmol. 45:(Suppl):2001;S261-267.
67. Wang F., Lidow M.S. α2A-adrenergic receptors are expressed by diverse cell types in the fetal primate cerebral wall. J Comp Neurol. 378:1997;493-507.
68. Wang R., Macmillan L.B., Fremeau R.T. Jr, Magnuson M.A., Lindner J., Limbird L.E. Expression of α2-adrenergic receptor subtypes in the mouse brain evaluation of spatial and temporal information imparted by 3 kb of 5′ regulatory sequence for the α2A AR-receptor gene in transgenic animals . Neuroscience. 74:1996;199-218.
69. Wang R.X., Limbird L.E. Distribution of mRNA encoding three α2-adrenergic receptor subtypes in the developing mouse embryo suggests a role for the α2A subtype in apoptosis. Mol Pharmacol. 52:1997;1071-1080.
70. Wiche G., Oberkanins C., Himmler A. Molecular structure and function of microtubule-associated proteins. Int Rev Cytol. 124:1991;217-273.
71. Winzer-Serhan U.H., Leslie F.M. α2B adrenoceptor mRNA expression during rat brain development. Dev Brain Res. 100:1997;90-100.
72. Winzer-Serhan U.H., Raymon H.K., Broide R.S., et al. Expression of α2 adrenoceptors during rat brain development-I. α2A messenger RNA expression. Neuroscience. 76:1997;241-260.
73. Winzer-Serhan U.H., Raymon H.K., Broide R.S., et al. Expression of α2 adrenoceptors during rat brain development-II α2C messenger RNA expression and [3H]rauwolscine binding . Neuroscience. 76:1997;261-272.
74. Yamamoto H., Saitoh Y., Fukunaga K., Nishimura H., Miyamoto E. Dephosphorylation of microtubule proteins by brain protein phosphatases 1 and 2A, and its effect on microtubule assembly. J Neurochem. 50:1988;1614-1623.
75. Yoles E., Wheeler L.A., Schwartz M. α2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Invest Ophthalmol Vis Sci. 40:1999;65-73.